Dedicated to Innovation
As biotechnology innovators we are proud of our portfolio of non-provisional patent technologies. We are currently working on additional patents for pharmaceutical targets that will disrupt major therapeutic industries. Unlocking the power of delivery technology and cutting-edge Cannabinoids research we are at the forefront of early phase discovery for cannabinoid research.
Truetiva Cannabinoids Biotechnology Patents
Proprietary Cannabinoids Bioenhancers
Addresses the absorption rate of Cannabinoids into the system to amplify the effects for a sustained amount of time. We are the owners of early submissions for all natural bioenhancers applied to formulations involving cannabinoids. We have blocking technology for this use and are looking for motivated partners who want the strongest, longest-lasting Cannabinoids, or the most potent recreational formulations available. See our Bioenhancers page for more information.
Cannabinoids for Dermatitis
Addresses areas of dermatitis including seborrheic, eczema, psoriasis, itch, steroid resistant dermatitis, contact dermatitis, and atopic dermatitis. Truetiva is the only company that has these specific techs named for cannabinoids claimed in late 2017 and submitted for non-provisional making Truetiva the owner of this groundbreaking and blocking technology. We have reduced this technology to practice and have natural, organic, and safe formulations that are just as effective as the harmful pharmaceuticals currently prescribed and have long-lasting negative effects after prolonged use. We can achieve complete remission of some disease states that are only treated by current products. Patients who had daily flare-ups being treated with corticosteroids have reported clear skin for 6-12 months after 24 hours of treatment.
Cannabinoids for Cancer and Chemotherapy
Addresses a completely novel cancer therapeutic target for the cannabinoids. Anecdotal evidence among medical cannabis users have reported positive results when using cannabinoids while undergoing chemotherapy to treat cancer. Truetiva has modelled Cannabinoids into various targets and have found a unique mode of action of cannabinoids that would explain these findings. This is exciting for hard-to-treat cancers as a co-chemotherapeutic agent.
Cannabinoids for Cosmetics
Addresses skin lightening/brightening and anti-aging. We have developed a unique, skin lightening/brightening technology utilizing Cannabinoids as well as separate anti-aging technology. This is an alternative to skin damaging bleaching agents, many of which have been banned due to long-term skin damage. These technologies are blocking to almost all anti-aging Cannabinoids cosmetics currently on the market, and completely novel for evening out skin pigmentation.
Cannabinoids for Weight Loss
Addresses natural, gradual weight loss in men and women. We have achieved exceptional results with our proprietary formulation ready for market and we are seeking motivated partners for this product. Truetiva is a leader in this technology and have seen body weight reductions as much as 20% over 6 months with no increase in blood pressure common to stimulant weight loss supplements. Utilizing a tri-functional approach addressing hunger, metabolism, and inflammation, this new weight loss technology is extremely exciting.